Statistics
Publications
88
Citations
35.9K
H-Index
54
Active since
1989
Philip R. Dormitzer is an author at Pfizer (United States) specializing in infectious diseases, vaccinology, and virology.
Publications per year
1989–2024
88
88
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin et al. · Nature · 2020 · 1.6K citations · Full text
1–5 of 88